Cava’s Dip Looks Tasty, Why This Sell-Off Could Be a Gift
Cava Group has done what its customers do best: dip. After hitting an all-time high near $172 last November, the shares have slid to the high-$60s, roughly a 60% slide from the peak, even though the business keeps putting up solid numbers.
That kind of disconnect tends to create opportunity for patient investors who care more about unit economics than headlines.
» Read more about: Cava’s Dip Looks Tasty, Why This Sell-Off Could Be a Gift »
Read More
IonQ Stock Is on Fire, Will It Last?
If you’ve been tracking hot tech trends lately, you’ve probably noticed quantum computing popping up more and more. And no surprise, it’s one of the buzziest corners of the tech world, right alongside artificial intelligence.
In fact, a report two years ago from McKinsey predicted that quantum tech could unlock $1.3 trillion in value across industries like automotive,
» Read more about: IonQ Stock Is on Fire, Will It Last? »
Read More
Will This Tiny Quantum Stock 2x by 2030?
IonQ isn’t a household name yet. But give it time. This small-cap quantum computing company is pulling in some big-league attention and the numbers from early 2025 are starting to back it up.
You’re probably used to hearing about quantum computing like it’s some distant dream but in Q1 2025, that revenue hit $7.6 million.
» Read more about: Will This Tiny Quantum Stock 2x by 2030? »
Read More
Billionaire Loves These Stocks Most of All
Stanley Druckenmiller doesn’t toss around stock picks like confetti. When he makes a move, it matters not just because of his track record (which is ridiculous by the way) but because his strategy blends macro trends with razor-sharp stock selection.
In 2025, he’s not chasing headlines. He’s making some bold, high-conviction bets, and a few of them are pretty surprising.
» Read more about: Billionaire Loves These Stocks Most of All »
Read More
Is The Stock with Ticker AI Finally a Buy?
C3.ai shares are back at price levels investors haven’t seen since early 2023, and the reasons are downright concerning.
The artificial intelligence firm with ticker AI has endured a brutal year that began in January when the share price was cut in half. The torpedos keeping hitting the bow, as evidence by the latest business update that pointed to a steep revenue shortfall.
» Read more about: Is The Stock with Ticker AI Finally a Buy? »
Read MoreThe Burst
UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read MoreThe Spotlight
Is Target Stock a Hidden Gem for Patient Value Investors?
Target (NYSE: TGT) hasn’t had the best run lately. In fact, shares have slid 29.9% so far this year, a sharp contrast to the broader market, with the S&P 500 flat on the year. It’s a tough pill to swallow, especially when you consider Target was already on the back foot coming into 2025.
But here’s the twist,
» Read more about: Is Target Stock a Hidden Gem for Patient Value Investors? »
Read MoreThe Daily
Here's Why Uranium Energy Stock Jumped 24.8% in September
Key Points
-
The U.S. government announced it would take steps to support domestic production and enrichment of nuclear materials.
» Read more about: Here's Why Uranium Energy Stock Jumped 24.8% in September »